Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Uses of BNIPXL-beta in premature canities

Uses of BNIPXL-beta in premature canities

US Patent 8178293 · Granted May 15, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Molecular signature representative of dysfunctions in epidermal homeostasis2017
Process for evaluating active agent(s) capable of preserving the functionality o2017
Administration of pyridinedicarboxylic acid compounds for stimulating or inducin2015
Administration of coumarin, butylated hydroxyanisole and ethoxyquine for the tre2015
Administation of ellagic acid for the treatment of canities2014
Inhibitors of 15-hydroxyprostaglandin dehydrogenase for stimulating pigmentation2014
Derivative of glucose and vitamin F, compositions comprising it, uses and prepar2014
Combination of a microorganism and a phytosphingosine derivative, composition, m2014
Administration of compounds that increase glutathione levels in the melanocytes 2013
Administration of agents mimicking dopachrome tautomerase (TRP-2) activity for p2013
Administration of agents mimicking dopachrome tautomerase (TRP-2) activity for p2013
Administration of coumarin, butylated hydroxyanisole and ethoxyquine for the tre2013